RE:RE:VERY NICE & VERY REASSURING DATA!!enriquesuave wrote: Yes. IMO this confirm that there is Avery good chance that Efficacy will be unsurpassed and way passed Keytruda's 19% 12 months CR rate. TLD-1433 May make the competition look like placebos which have way more treatment sessions and side effects. We will hopefully win on all fronts. Efficacy, Safety, Patient comfort and morbidity, with only 2 Single Treatments Vs the competition which has from 4 to 36 treatments . All IMO do your DD
We have 4(450 days cancer free) +4(360 days cancer free) =8 out of 33 patients beated keytruda 's 19% already, not to say we still have 7(270 days cancer free) +7(180 days cancer free) =14 /(out of33) to add up inside the 360 days cancer free list in the not too long future.... Keytruda compare with TLD1433, is no thing....